High and low risk prostate carcinoma determined by histologic grade and proliferative activity

Cancer

Volumn 79, Issue 10, 1997, Pages 1956-1963

  Chiusa, Luigi ^a   Galliano, Diego ^a   Formiconi, Andrea ^b   Di Primio, Otello ^c,d   Pich, Achille ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Ospedale Civile   (Italy)

Author keywords

argyrophilic nucleolar organizer regions; morphometry; proliferative activity; prostate carcinoma; risk groups

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CELL NUCLEUS; CHROMOSOME NOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY, NEEDLE; CARCINOMA; CELL DIVISION; CELL NUCLEOLUS; CELL NUCLEUS; COLORING AGENTS; FIXATIVES; FORMALDEHYDE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEOLUS ORGANIZER REGION; PARAFFIN EMBEDDING; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SILVER; SURVIVAL ANALYSIS; SURVIVAL RATE; TISSUE FIXATION;

EID: 0030973379     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1956::AID-CNCR17>3.0.CO;2-U     Document Type: Article

References (33)

1. Withmore WF. The natural history of prostatic cancer. Cancer 1973;32:1104-12.
2. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate. Relationship to local and distant spread. Hum Pathol 1992;23:258-66.
3. Hanks GE. Optimizing the radiation treatment and outcome of prostate cancer. Int J Radiat Oncol Biol Phys 1985; 11:1235-45.
4. Mostofi FK, Sesterhenn IA, Sobin LH. Histological typing of prostate tumours. Geneva: World Health Organization, 1980.
5. Gleason D, Mellinger G, and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;11:58-64.
6. Foster CS, Mostofi FK. Prostate cancer. Quo vadis? Hum Pathol 1992;23:402-6.
7. Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. J Urol 1982;128:729-34.
8. Blom JH, Ten Kate FJ, Schroeder FH, Van der Heul RO. Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer. Urol Res 1990;18:93-9.
9. Shaeffer J, Tegeler JA, Kuban DA, Philput CB, El Madhi AM. Nuclear roundness factor and local failure from definitive radiation therapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 1992;24:431-4.
10. Vesalainen S, Lipponen P, Talja M, Kasurinen J, Syrjanen K. Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas. Prostate 1995;27:110-7.
11. Tannenbaum M, Tannenbaum S, DeSandis PN, Olsson CA. Prognostic significance of nucleolar surface area in prostatic cancer. Urology 1982;19:546-51.
12. Gall JG, Pardue ML. Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci U S A 1969;63:378-83.
13. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
14. Derenzini M, Sirri V, Trerè D. Nucleolar organizer regions in tumor cells. Cancer J 1994;7:71-7.
15. Pich A, Chiusa L, Margaria E. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Cancer Detect Prev 1995;19:282-91.
16. Deschênes J, Weidner N. Nucleolar organizer regions (NORs) in hyperplastic and neoplastic prostate disease. Am J Surg Pathol 1990;14:1148-55.
17. Ghazizadeh M, Sasaki Y, Oguro T, Aihara K. Silver staining of nucleolar organizer regions in prostatic lesions. Histopathology 1991;19:369-72.
18. Eskelinen M, Lipponen P, Syrjanen K. Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma. Anticancer Res 1992;12:1635-40.
19. Masai M, Abe K, Akimoto S, Yatani R, Shimazaki J. Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates. Prostate 1992;20:1-13.
20. Kawase N, Shiokawa A, Ota H, Saitoh T, Yoshida H, Kazama K. Nucleolar organizer regions and PCNA expression in prostatic cancers. Pathol Int 1994;44:213-22.
21. Helpap B, Riede C. Nucleolar organizer regions in low-and high-grade carcinomas of the prostate. World J Urol 1995; 13:195-9.
22. Contractor H, Rüshoff J, Hanish T, Ulshöfer B, Neumann K, Schultze-Seemann W, et al. Silver stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis. Urol Int 1991;46:9-14.
23. Akakura K, Akimoto S, Ohki T, Igarashi T, Murakami S, Shimazaki J. Radiation therapy for prostate cancer confined to pelvis. Int J Urol 1994;1:268-72.
24. Kaplan EL, Meier P. Non parametric estimation for incomplete observations. J Am Stat Assoc 1958;53:457-81.
25. Cox DR. Regression models and life tables (with discussion). J R Stat B 1972;34:187-220.
26. Dixon WJ, Brown MG, Engelman L, Hill MA, Jennrich RI, editors. BMPD statistical software manual. Berkeley, CA: University of California Press, 1990.
27. Hansen AB, Østergård B. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue. Virchows Arch A Pathol Anal Histopathol 1990;417:9-13.
28. Helpap B, Riede C. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AHH) and prostatic carcinoma. Pathol Res Pract 1995;191:381-90.
29. Wang N, Stenkvist BG, Tribukait B. Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy. Anal Quant Cytol Histol 1992;14:210-6.
30. Mohler JL, Metts JC, Zhang XZ, Maygarden SJ. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison. Anal Quant Cytol Histol 1994;16:415-20.
31. Cohen RJ, Glezerson G, Haffejee Z, Afrika D. Prostatic carcinoma: histological and immunohistological factors affecting prognosis. Br J Urol 1990;66:405-10.
32. Ahiskali R, Alican Y, Ekicioglu G, Cevik I, Kullu S, Akdas A. Evaluation of three different AgNOR counting methods in advanced carcinomas of the prostate. Prostate 1995;26:105-10.
33. Öfner D, Riedman B, Maier H, Hittmair A, Rumer A, Tötsch M, et al. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma. Correlation with tumour stage and long-term survival. J Pathol 1995; 175:441-8.